Skip to main content
. 2014 May 30;4:5116. doi: 10.1038/srep05116

Table 2. Genotype distributions and allele frequencies of five examined polymorphisms in STK39 gene between hypertensive patients and normotensive controls.

Polymorphism* Patients (n = 1009) Controls (n = 756) χ2 P**
rs6749447 CC 488 (48.36) 566 (74.87)    
  CA 435 (43.11) 175 (23.15) 132.97 <0.001
  AA 86 (8.52) 15 (1.98)    
  A allele 30.08% 13.56% 133.20 <0.001
rs12692877 GG 710 (70.37) 531 (70.24)    
  GC 258 (25.57) 208 (27.51) 4.95 0.084
  CC 41 (4.06) 17 (2.25)    
  C allele 16.85% 16.01% 0.45 0.504
rs35929607 AA 309 (30.26) 236 (31.22)    
  AG 499 (49.45) 377 (49.87) 0.29 0.866
  GG 201 (19.92) 143 (18.92)    
  G allele 44.65% 43.85% 0.22 0.636
rs3754777 GG 562 (55.70) 629 (83.20)    
  GA 384 (38.06) 119 (15.74) 152.86 <0.001
  AA 63 (6.24) 8 (1.06)    
  A allele 25.27% 8.93% 154.62 <0.001
rs6433027 CC 178 (17.64) 212 (28.04)    
  CT 490 (48.56) 358 (47.35) 33.52 <0.001
  TT 341 (33.80) 186 (24.60)    
  T allele 58.08% 48.28% 33.39 <0.001

*Genotypes of five examined polymorphisms were expressed as count (percentage).

**P values were computed by using the χ2 test based on the 3 × 2 contingency tables for the genotype comparison and on the 2 × 2 contingency tables for the allele comparison.